NanoViricides, Inc. (NNVC)
1.09
+0.01
(+0.93%)
USD |
NYAM |
Sep 09, 15:06
NanoViricides Total Liabilities (Quarterly) : 1.065M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.065M |
| December 31, 2025 | 1.196M |
| September 30, 2025 | 1.182M |
| June 30, 2025 | 1.306M |
| March 31, 2025 | 1.199M |
| December 31, 2024 | 1.184M |
| September 30, 2024 | 1.633M |
| June 30, 2024 | 1.359M |
| March 31, 2024 | 0.8133M |
| December 31, 2023 | 0.9511M |
| September 30, 2023 | 2.448M |
| June 30, 2023 | 2.034M |
| March 31, 2023 | 0.3487M |
| December 31, 2022 | 0.4646M |
| September 30, 2022 | 0.5184M |
| June 30, 2022 | 0.4128M |
| March 31, 2022 | 0.3867M |
| December 31, 2021 | 0.3443M |
| September 30, 2021 | 0.8695M |
| June 30, 2021 | 0.3511M |
| March 31, 2021 | 0.8713M |
| December 31, 2020 | 0.3393M |
| September 30, 2020 | 1.866M |
| June 30, 2020 | 2.156M |
| March 31, 2020 | 2.213M |
| Date | Value |
|---|---|
| December 31, 2019 | 3.896M |
| September 30, 2019 | 2.656M |
| June 30, 2019 | 2.848M |
| March 31, 2019 | 2.677M |
| December 31, 2018 | 1.164M |
| September 30, 2018 | 1.392M |
| June 30, 2018 | 0.8819M |
| March 31, 2018 | 3.194M |
| December 31, 2017 | 7.808M |
| September 30, 2017 | 6.747M |
| June 30, 2017 | 6.681M |
| March 31, 2017 | 6.174M |
| December 31, 2016 | 12.22M |
| September 30, 2016 | 14.00M |
| June 30, 2016 | 13.59M |
| March 31, 2016 | 14.34M |
| December 31, 2015 | 12.46M |
| September 30, 2015 | 11.59M |
| June 30, 2015 | 12.40M |
| March 31, 2015 | 13.74M |
| December 31, 2014 | 17.10M |
| September 30, 2014 | 12.19M |
| June 30, 2014 | 21.20M |
| March 31, 2014 | 8.920M |
| December 31, 2013 | 12.68M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.22M |
| Shareholders Equity (Quarterly) | 9.154M |
| Current Ratio | 3.170 |